Page last updated: 2024-08-23

paclitaxel and Deafness, Transitory

paclitaxel has been researched along with Deafness, Transitory in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Casale, M; Di Peco, V; Firrisi, L; Greco, F; Onori, N; Salvinelli, F; Santini, D; Tonini, G; Vincenzi, B1

Other Studies

1 other study(ies) available for paclitaxel and Deafness, Transitory

ArticleYear
Bilateral irreversible hearing loss associated with the combination of carboplatin and paclitaxel chemotherapy: a unusual side effect.
    Journal of experimental & clinical cancer research : CR, 2003, Volume: 22, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Audiometry; Carboplatin; Female; Hearing Loss; Humans; Neoplasm Staging; Ovarian Neoplasms; Paclitaxel; Time Factors; Treatment Outcome

2003